Related Experiment Video
Updated: Apr 21, 2026
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Comorbidity as predictor poor prognosis for patients with advanced head and neck cancer treated with major surgery
Go Omura1, Mizuo Ando1, Yuki Saito1
1Department of Otolaryngology and Head and Neck Surgery, Faculty of Medicine, the University of Tokyo, Tokyo, Japan.
Background:
The impact of comorbidities on patients with advanced head and neck cancer treated with major surgery has not been reported before.
Methods:
We retrospectively reviewed clinical charts between 2004 and 2011 at our institution and identified 185 patients with clinical stage III to IV head and neck cancer treated with major surgery. Comorbidities were scored using the Adult Comorbidity Evaluation-27 (ACE-27) index manual.
Results:
Patients with ACE-27 ≥2 had significantly worse overall survival (OS) and disease-specific survival (DSS) than those with ACE-27 ≤1 (p < .0001 and p = .0047, respectively). Multivariate analyses revealed that ACE-27 ≥2 and extracapsular spread (ECS) were independently significant adverse prognostic factors for OS and DSS. In addition, patients with ACE-27 ≥2 had a higher incidence of distant metastases (p = .0057).
Conclusion:
The current study suggests that comorbidities may predict poor prognosis and development of distant metastases for patients with advanced head and neck cancer treated with major surgery.
Related Concept Videos
01:21Cancer Survival Analysis
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression